These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11590250)

  • 21. Cardiovascular consequences of renal anaemia and erythropoietin therapy.
    Eckardt KU
    Nephrol Dial Transplant; 1999 May; 14(5):1317-23. PubMed ID: 10344393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of renal anaemia with erythropoiesis-stimulating agents in predialysis chronic kidney disease patients: Haemoglobin profile during the 6 months before initiation of dialysis.
    Kawahara K; Minakuchi J; Yokota N; Suekane H; Tsuchida K; Kawashima S
    Nephrology (Carlton); 2015 Dec; 20 Suppl 4():29-32. PubMed ID: 26456375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical experience with Repotin, a locally produced recombinant human erythropoietin, in the treatment of anaemia of chronic renal failure in South Africa.
    Swanepoel CR; Moosa MR; Rowland GF; Meyers AM; Botha BP; Smart AJ; Goodman R; Schall R; Keogh HJ; Merrifield EH
    S Afr Med J; 1996 Oct; 86(10):1266-9. PubMed ID: 8955732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Frequency of anaemia and indications for treatment with epoetin in chronic renal failure at the pre-dialysis stage].
    Jungers PY; Nguyen-Khoa T; Joly D; Choukroun G; Massy ZA; Jungers P
    Presse Med; 2003 Feb; 32(5):212-6. PubMed ID: 12610461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The anaemia research nurse in effective multi-disciplinary management of patients on erythropoietin.
    Bennett L
    EDTNA ERCA J; 1998; 24(3):38-9. PubMed ID: 10392079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anaemia in chronic kidney disease: target haemoglobin concentration in patients treated with erythropoesis stimulating agents].
    Klarić D
    Acta Med Croatica; 2009 Sep; 63 Suppl 1():7-10. PubMed ID: 20232546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. UK Renal Registry 11th Annual Report (December 2008): Chapter 9 Haemoglobin, ferritin and erythropoietin amongst patients receiving dialysis in the UK in 2007: national and centre-specific analyses.
    Richardson D; Ford D; Gilg J; Williams AJ
    Nephron Clin Pract; 2009; 111 Suppl 1():c149-83. PubMed ID: 19542697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The CREATE trial--building the evidence.
    Eckardt KU;
    Nephrol Dial Transplant; 2001; 16 Suppl 2():16-8. PubMed ID: 11369844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stepwise correction of anaemia by subcutaneous administration of human recombinant erythropoietin in patients with chronic renal failure maintained by continuous ambulatory peritoneal dialysis.
    Stevens JM; Auer J; Strong CA; Hughes RT; Oliver DO; Winearls CG; Cotes PM
    Nephrol Dial Transplant; 1991; 6(7):487-94. PubMed ID: 1922910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-erythropoietin-based anaemia management in chronic kidney disease.
    Hörl WH
    Nephrol Dial Transplant; 2002; 17 Suppl 11():35-8. PubMed ID: 12386256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis.
    Phrommintikul A; Haas SJ; Elsik M; Krum H
    Lancet; 2007 Feb; 369(9559):381-8. PubMed ID: 17276778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Multicenter study of darbepoetin alfa in the treatment of anemia secondary to chronic renal insufficiency on dialysis].
    Martínez Castelao A; Reyes A; Valdés F; Otero A; López de Novales E; Pallardó L; Tabernero JM; Hernández Jaras J; Lladós F
    Nefrologia; 2003; 23(2):114-24. PubMed ID: 12778875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correction of anaemia of chronic renal failure with recombinant human erythropoietin: safety and efficacy of one year's treatment in a European multicentre study of 150 haemodialysis-dependent patients.
    Sundal E; Kaeser U
    Nephrol Dial Transplant; 1989; 4(11):979-87. PubMed ID: 2516891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron.
    Silverberg DS; Wexler D; Blum M; Tchebiner JZ; Sheps D; Keren G; Schwartz D; Baruch R; Yachnin T; Shaked M; Schwartz I; Steinbruch S; Iaina A
    Nephrol Dial Transplant; 2003 Jan; 18(1):141-6. PubMed ID: 12480972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer.
    Bokemeyer C; Aapro MS; Courdi A; Foubert J; Link H; Osterborg A; Repetto L; Soubeyran P
    Eur J Cancer; 2004 Oct; 40(15):2201-16. PubMed ID: 15454245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia.
    Marsillach J; Martínez-Vea A; Marcas L; Mackness B; Mackness M; Ferré N; Joven J; Camps J
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):347-9. PubMed ID: 17324148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Locatelli F; Pisoni RL; Combe C; Bommer J; Andreucci VE; Piera L; Greenwood R; Feldman HI; Port FK; Held PJ
    Nephrol Dial Transplant; 2004 Jan; 19(1):121-32. PubMed ID: 14671047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients.
    Furuland H; Linde T; Ahlmén J; Christensson A; Strömbom U; Danielson BG
    Nephrol Dial Transplant; 2003 Feb; 18(2):353-61. PubMed ID: 12543892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of anaemia in renal failure.
    Macdougall I
    EDTNA ERCA J; 1999; 25(1):19-22. PubMed ID: 10418372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy and safety of CERA in anemia correction in predialysis patients--Croatian experience].
    Bubić I; Prkacin I; Racki S
    Acta Med Croatica; 2012 Oct; 66 Suppl 2():42-6. PubMed ID: 23513415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.